| Stable topical compositions of fenoldopam |
2022-8-10 |
2022-10-19 |
|
| Fenoldopam topical formulations for treating skin disorders |
2022-8-05 |
2022-10-19 |
|
| Topical montelukast formulations |
2022-8-01 |
2022-10-01 |
|
| Preparation of trifarotene and intermediates and polymorphs thereof |
2022-6-09 |
2022-8-01 |
|
| Oral care device |
2022-4-12 |
2022-10-20 |
|
| Topical montelukast formulations |
2021-8-02 |
2021-12-23 |
|
| Compositions comprising desoximetasone and tazarotene |
2020-12-30 |
2023-2-23 |
|
| Topical capecitabine for the treatment of hyperproliferative skin conditions |
2020-7-06 |
2020-8-31 |
|
| Topical montelukast for treatment of atopic dermatitis |
2020-1-09 |
2020-7-30 |
|
| Process for the preparation of 17-desoxy-corticosteroids |
2017-1-09 |
2018-10-30 |
2018-10-30 |
| Process for the preparation of a stable polymorphic form of Atovaquone |
2014-12-17 |
2016-5-10 |
2016-5-10 |
| Process for preparation of 1,2,3-triazole-4 carboxamides |
2013-12-03 |
2014-6-05 |
|
| Process for preparing malathion for pharmaceutical use |
2013-8-29 |
2015-2-17 |
2015-2-17 |
| Composition and method for improved bioavailability and enhanced brain delivery … |
2013-6-04 |
2013-9-09 |
|
| Process for preparing a crystalline form of halobetasol propionate |
2013-1-07 |
2013-8-22 |
|
| Medicinal composition for oral administration |
2012-10-22 |
2013-1-24 |
|
| Oral suspension of prednisolone acetate |
2012-5-30 |
2012-9-20 |
|
| Process for the preparation of 2-phenyl-1,3-propanediol |
2011-9-05 |
2016-1-12 |
2016-1-12 |
| Process for the purification of ropinirole hydrochloride |
2010-9-02 |
2011-3-17 |
|
| Non-sedating barbiturate compounds as neuroprotective agents |
2010-4-13 |
2010-8-05 |
|
| Method of treating movement disorders using barbituric acid derivatives |
2010-3-02 |
2010-3-25 |
|
| Composition and method for improved bioavailability and enhanced brain delivery … |
2010-1-19 |
2010-6-10 |
|
| Controlled delivery system of antifungal and keratolytic agents for local … |
2010-1-05 |
2012-9-04 |
2012-9-04 |
| Combination product of spironolactone and doxycycline |
2009-10-11 |
2010-4-08 |
|
| Method of improving bioavailability for non-sedating barbiturates |
2007-11-14 |
2008-6-05 |
|
| Vessel for dispensing small quantity of hardly spilling compound |
2007-10-31 |
2008-2-28 |
|
| Use of non-sedating barbiturate compounds in preparation of neuroprotective … |
2007-6-05 |
2007-9-28 |
|
| Process for preparing 1-methoxymethyl 5,5-diphenybarbituric acid |
2007-3-27 |
2007-7-19 |
|
| Non-sedating barbiturate compounds as neuroprotective agents |
2007-2-02 |
2009-10-08 |
2009-10-08 |
| Anti-histamine compositions and use thereof |
2007-1-25 |
2009-2-19 |
|
| Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
2007-1-01 |
2010-12-30 |
|
| Process for preparing ondansetron hydrochloride dihydrate having a defined … |
2006-11-06 |
2007-3-08 |
|
| Taste masking spill-resistant formulation |
2006-9-08 |
2006-9-28 |
|
| Method for the preparation of 6-α fluoro corticosteroids |
2006-7-13 |
2010-5-18 |
2010-5-18 |
| Stable liquid desoximethasone compositions with reduced oxidized impurity |
2006-5-26 |
2012-10-02 |
2012-10-02 |
| Stable aqueous-based emulsion formulation comprising urea and salicylic acid … |
2006-3-16 |
2006-11-02 |
|
| Controlled delivery system of antifungal and keratolytic agents for local … |
2005-12-20 |
2006-6-08 |
|
| Process of preparing a crystalline azithromycin monohydrate |
2005-8-25 |
2006-6-01 |
|
| Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4h- carbazol-4- … |
2005-8-17 |
2006-7-20 |
|
| Thermoreversible pharmaceutical formulation for anti-microbial agents … |
2005-8-16 |
2006-4-13 |
|
| Topical gel formulation comprising organophosphate insecticide and its … |
2005-7-12 |
2006-2-16 |
|
| Non-sedating barbituric acid derivatives |
2005-6-28 |
2006-2-16 |
|
| Process for preparing ondansetron hydrochloride dihydrate having a defined … |
2005-5-05 |
2007-10-30 |
2007-10-30 |
| Non-sedating barbiturate compounds as neuroprotective agents |
2004-11-15 |
2006-11-02 |
2006-11-02 |
| Non-sedative barbiturate which provides a neuroprotective effect for protection … |
2004-7-22 |
2012-1-31 |
|
| Novel topical steroid cream formulations |
2004-5-19 |
2006-2-15 |
|
| Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by … |
2003-8-24 |
2006-12-31 |
|
| Ibuprofen suspension |
2003-6-17 |
2010-10-20 |
|
| Process for preparing gabapentin |
2003-4-16 |
2005-12-18 |
|
| Process for preparing gabapentin |
2003-4-16 |
2003-10-30 |
|
| Taste masking spill-resistant formulation |
2003-3-13 |
2003-12-25 |
|
| Non-sedating barbituric acid derivatives |
2003-1-30 |
2003-9-02 |
|
| Taste masking spill-resistant formulation |
2002-10-22 |
2003-7-03 |
|
| Container for dispensing spill-resistant formulations |
2002-10-22 |
2003-7-03 |
|
| Process for preparing non-hygroscopic sodium valproate composition |
2002-1-24 |
2002-8-01 |
|
| Process for preparing non-hygroscopic sodium valproate composition |
2002-1-24 |
2002-8-06 |
|
| Process for purification of warfarin acid, warfarin alkali metal salts and … |
2001-12-28 |
2004-6-16 |
|
| PREPARATION OF WARFARINA SODICA FROM WARFARINA ACIDA. |
2001-12-28 |
2005-9-16 |
2005-9-16 |
| Preparation of warfarin sodium warfarin acid |
2001-12-28 |
2002-9-19 |
|
| Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by … |
2001-12-28 |
2002-9-19 |
|
| Process for purification of warfarin acid, warfarin alkali metal salts and … |
2001-12-28 |
2002-9-19 |
|
| Non-sedating barbiturate compounds as neuroprotective agents |
2001-7-26 |
2002-5-02 |
|
| Non-sedating barbiturate compounds as neuroprotective agents |
2001-7-26 |
2008-4-23 |
|
| Process for synthesis of pure warfarin acid, warfarin alkali metal salts and … |
2001-2-28 |
2002-8-29 |
|